Analytical Data
-
基因名
D8S2298E
- Application
-
别名
UBXN8; D8S2298E; REP8; UBXD6; UBX domain-containing protein 8; Reproduction 8 protein; Rep-8 protein; UBX domain-containing protein 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O00124
-
表达区间
1-270aa
-
氨基酸序列
MASRGVVGIFFLSAVPLVCLELRRGIPDIGIKDFLLLCGRILLLLALLTLIISVTTSWLNSFKSPQVYLKEEEEKNEKRQKLVRKKQQEAQGEKASRYIENVLKPHQEMKLRKLEERFYQMTGEAWKLSSGHKLGGDEGTSQTSFETSNREAAKSQNLPKPLTEFPSPAEQPTCKEIPDLPEEPSQTAEEVVTVALRCPSGNVLRRRFLKSYSSQVLFDWMTRIGYHISLYSLSTSFPRRPLAVEGGQSLEDIGITVDTVLILEEKEQTN
-
分子量
30.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
D8S2298E is a recombinant protein that has garnered significant attention in biomedical research, particularly concerning its potential roles in various diseases and therapeutic applications. As a variant derived from the D8S gene family, this protein is believed to play a crucial part in cellular signaling pathways, gene regulation, and possibly in the immune response. Recent studies have suggested that aberrations in the expression and function of D8S2298E may be linked to the pathogenesis of several conditions, including cancer and autoimmune disorders. Understanding the structure and function of this protein is essential for elucidating its biological roles. Advances in recombinant DNA technology have enabled the production of purified D8S2298E, allowing researchers to conduct in-depth studies on its properties and interactions with other cellular components. These investigations are expected to pave the way for novel therapeutic strategies that target this protein, either by modulating its activity or by utilizing it as a biomarker for disease diagnosis and prognosis. As research progresses, the insights gained from studying D8S2298E could contribute to the development of innovative interventions that leverage this protein's unique characteristics, ultimately improving patient outcomes and enhancing our understanding of complex biological systems.
